Private limited company · Putte · incorporated on 15/11/2022
| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| Gross margin | 14,1 k € | -62.6% | 37,8 k € | -20.8% | 47,7 k € | |
| EBITDA | 13,0 k € | -65.0% | 37,2 k € | -20.9% | 47,0 k € | |
| Operating profit | -3,6 k € | -110.5% | 33,7 k € | -26.9% | 46,2 k € | |
| Profit/loss | -7,1 k € | -129.5% | 24,0 k € | -28.9% | 33,8 k € | |
| Equity | 51,7 k € | -12.0% | 58,8 k € | +69.1% | 34,8 k € | |
| Total assets | 143,9 k € | +17.6% | 122,3 k € | +95.0% | 62,7 k € | |
| Cash | 12,5 k € | -69.5% | 41,1 k € | +33.3% | 30,9 k € | |
| Debts | 92,2 k € | +45.1% | 63,5 k € | +127.3% | 28,0 k € | |
Private limited company loss-making in the latest fiscal year. Cash position declining (-69.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
XONAR is a Private limited company incorporated in 2022. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Putte.